AI Epigenetic Chromatin Modeling for Base-Resolution Variant Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing genomics data analysis methods struggle to accurately identify genetic variants causing extreme levels of gene expression due to confounding factors and incomplete data representation, leading to reduced classification accuracy and difficulty in diagnosing pathogenicity of genetic diseases.
Innovation Solution
An artificial intelligence-based approach that utilizes a chromatin model to process genomic data at base resolution, incorporating epigenetic signals to identify rare variants causing extreme gene expression levels by controlling for confounders using a causality model and generating causality scores.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If existing genomics data analysis methods are used, then analysis can be performed with available tools, but classification accuracy is reduced due to confounding factors and incomplete data representation
Solution Approach 1:
The patent segments the analysis into multiple independent components: chromatin accessibility data, histone modification data, DNA sequence features, and gene expression data are processed separately through distinct neural network branches before being integrated. This segmentation allows each feature type to be optimized independently while reducing confounding effects between different data modalities.
Solution Approach 2:
The patent creates a composite analytical model that integrates multiple types of genomic data (chromatin accessibility, histone modifications, DNA sequences, and gene expression) into a unified deep learning framework. This composite approach combines the strengths of different data types to achieve higher classification accuracy than any single data type alone.
2Measurement precision
If deep learning models integrate multiple data types, then classification accuracy improves, but model complexity increases
Solution Approach 1:
The deep learning model is divided into separate processing branches for different data types (chromatin accessibility, histone modifications, DNA sequences, gene expression), with each branch specialized for its input type. This modular segmentation reduces training complexity while maintaining the benefits of multi-modal integration.
Solution Approach 2:
The patent introduces intermediate representation layers that transform raw genomic data into standardized feature vectors before final integration. These intermediary layers act as adapters between different data modalities, simplifying the integration process and reducing overall model complexity.
3Measurement precision
If rare variants are identified with higher sensitivity, then diagnostic capabilities improve, but false positives increase due to confounding factors
Solution Approach 1:
The patent combines multiple independent lines of evidence (chromatin accessibility, histone modifications, DNA sequence conservation, and gene expression patterns) into a composite scoring system. Rare variants are only flagged as high-confidence when they show consistent signals across multiple data types, thereby increasing sensitivity while reducing false positives through cross-validation.
Solution Approach 2:
The model incorporates feedback mechanisms where predictions from one data type inform the weighting and interpretation of other data types. Confounding factors detected in one modality can suppress signals in other modalities, creating a self-correcting system that reduces false positives while maintaining sensitivity to true rare variants.
Data Source
AI summary
The technology disclosed relates to reliably identifying variants that cause extreme levels of gene expression. Extreme levels of gene expression include under expression and over expression. Then, these variants are used to train artificial intelligence based models for a variety of prediction tasks. One example of the prediction tasks is to produce per-base resolution for chromatin sequences. Another example of the chromatin task is to produce gene expression changes caused by the reliably identified variants.